Home / Tag Archives: NYSE: VRX

Tag Archives: NYSE: VRX

Healthcare News updates: Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX)

Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned partner, Bausch + Lomb, a leading global eye health company, recently declared the introduction of Bausch + Lomb AQUALOX® contact lenses, the first new innovation in the bi-weekly contact lens category in half a decade, to the Japanese market. …

Read More »